EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Chemical Teratogen ExposureContraception BehaviorContraception
Interventions
BEHAVIORAL

EMR Referral

EMR referral to California Teratogen Information Services (CTIS) for use of category D or X medication.

BEHAVIORAL

CTIS Counseling

Counseling from MotherToBaby teratogen information specialist.

BEHAVIORAL

Baseline Questionnaire

Baseline Questionnaire capturing contraceptive use immediately after counseling with MotherToBaby

BEHAVIORAL

Contraception Provision Appointment

Appointment with contraception provider to discuss contraception options.

BEHAVIORAL

3 Month Follow Up Questionnaire

Questionnaire 3 months after CTIS counseling to assess contraception use and plans

BEHAVIORAL

6 Month Follow Up Questionnaire

Questionnaire 6 months after CTIS counseling to assess contraception use and plans

Trial Locations (1)

92123

CTIS Pregnancy Health Information Line at the University of California San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02293213 - EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT | Biotech Hunter | Biotech Hunter